Related Experiment Video
Updated: Aug 14, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Anaemia after renal transplantation
M Lorenz1, W C Winkelmayer, W H Hörl
1Department of Medicine III, Medical University of Vienna, Vienna, Austria, and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA. matthias.lorenz@meduniwien.ac.at
Anaemia affects about 40% of kidney transplant patients, often due to iron deficiency or reduced erythropoietin. Despite being a cardiovascular risk, anaemia in these patients did not correlate with mortality or graft loss in this study.
Area of Science:
- Nephrology
- Transplantation Medicine
- Hematology
Background:
- Anaemia is a common complication in long-term renal transplant recipients, with prevalence around 40%.
- Prevalence increases with declining renal function, even in patients with functioning kidney grafts.
- Factors contributing to anaemia include erythropoietin deficiency, iron depletion, inflammation, and immunosuppressive medications.
Purpose of the Study:
- To investigate the prevalence and contributing factors of anaemia in renal transplant recipients.
- To assess the association between anaemia and mortality or graft loss.
- To highlight the need for improved anaemia management post-transplantation.
Main Methods:
- Analysis of patient data from long-term renal transplant recipients.
- Evaluation of haemoglobin concentration, creatinine clearance, and iron status parameters.
- Correlation analysis between anaemia, cardiovascular risk factors, mortality, and graft loss.
Main Results:
- Anaemia is prevalent, linked to graft function and iron store depletion.
- The proportion of hypochromic red blood cells may indicate iron supply issues and mortality risk.
- Anaemia was not associated with increased mortality or graft loss in this cohort, despite being a cardiovascular risk factor.
Conclusions:
- Anaemia is a significant issue in renal transplant recipients, often multifactorial.
- Current management of post-transplant anaemia requires more attention.
- Further research into erythropoietic agents' effects on endothelial progenitor cells may offer future cardiovascular risk reduction strategies.
More Related Videos
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
